A carregar...
Febuxostat in the management of hyperuricemia and chronic gout: a review
Febuxostat is a novel, potent, non-purine selective xanthine oxidase inhibitor, which in clinical trials demonstrated superior ability to lower and maintain serum urate levels below 6 mg/dL compared with conventionally used doses of allopurinol. Febuxostat was well tolerated in long term treatment i...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2643102/ https://ncbi.nlm.nih.gov/pubmed/19337428 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|